Investigating Alzheimer's Disease-Associated Genes Using Differential Splicing Frequency Analysis
Preprint
- 7 March 2025
- preprint
- Published by Qeios Ltd in Qeios Preprints
Abstract
Accurately quantifying the expression of individual isoforms remains a formidable challenge, especially in contexts like neurodegenerative diseases and cancers, which are noted for their high isoform diversity. The first contribution of the present study is the development of a new method, named differential splicing frequency analysis (DSFA), which enables more sensitive capture of the alternative splicing information in RNA-seq data. DSFA quantifies the expression levels of splicing junctions, rather than those of genes, isoforms or exons. Application of DSFA to the analysis of Alzheimer's disease (AD)-associated genes resulted in the identification of APP/58417N and APP/52804N as differentially expressed splicing junctions in human and mouse, respectively. Observed in a considerable portion of the re-analyzed RNA-seq datasets, the splicing frequencies of APP/58417N and APP/52804N were significantly decreased in AD groups. Such reductions in splicing frequencies lead to decreased production of secretory APP proteins, potentially playing a critical role in AD onset or progression. The present study has proposed over-expression of U1 snRNA as an effective method for modulating the splicing frequencies of splicing junctions, thereby rapidly establishing cellular or animal AD models. Therefore, the present study has provided new methods, preliminary results, and valuable insights, advancing the understanding of the functions of U1 snRNA and the roles of alternative splicing in its associated diseases.Keywords
All Related Versions
This publication has 13 references indexed in Scilit:
- Long-read transcript sequencing identifies differential isoform expression in the entorhinal cortex in a transgenic model of tau pathologyNature Communications, 2024
- Comparative evaluation of full-length isoform quantification from RNA-SeqBMC Bioinformatics, 2021
- Neurodegenerative diseases: a hotbed for splicing defects and the potential therapiesTranslational Neurodegeneration, 2021
- Presenilin 1 mutation likely contributes to U1 small nuclear RNA dysregulation and Alzheimer's disease–like symptomsNeurobiology of Aging, 2021
- Abundancy of polymorphic CGG repeats in the human genome suggest a broad involvement in neurological diseaseScientific Reports, 2021
- Benchmark analysis of algorithms for determining and quantifying full-length mRNA splice forms from RNA-seq dataBioinformatics, 2015
- Fastq_clean: An optimized pipeline to clean the Illumina sequencing data with quality control2014
- U1 snRNP Determines mRNA Length and Regulates Isoform ExpressionCell, 2012
- U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylationNature, 2010
- Levels and Alternative Splicing of Amyloid β Protein Precursor (APP) Transcripts in Brains of APP Transgenic Mice and Humans with Alzheimer's DiseaseJournal of Biological Chemistry, 1995